Mycoplasma Testing: PCR vs Culture for Sensitivity and Speed

Mycoplasma testing is the routine screening of cell cultures for Mycoplasma contamination, the silent infection that alters cell metabolism, growth, and experimental results without any visible sign. The two standard detection routes are molecular and cultivation-based: PCR amplification of conserved mycoplasma sequences, or culture of the organisms in broth and agar. Both answer the same question, contamination yes or no, through different detection logic.

Labs choose between the methods on sensitivity, speed, and what each can and cannot detect, and many labs use both in combination rather than either alone. This guide compares PCR and culture testing, explains what each method's result actually means, and covers the screening decisions that keep cultures trustworthy.

Why Mycoplasma Testing Cannot Be Skipped

Mycoplasma contamination changes the experiment before it announces itself: the organisms compete for nutrients, alter host gene expression and metabolism, and shift the very measurements a cell-based experiment exists to produce. Because there is no visible clouding or color change in most cases, only deliberate testing reveals it, which is why the test is a scheduled procedure rather than a response to something looking wrong.

Contamination also spreads: a contaminated culture shares hoods, media, and pipettes, and the silent window before detection is when the spread happens. Testing on a fixed schedule, plus testing every new culture that enters the lab, is what converts the risk from an invisible background threat into a managed one. For teams that want testing schedules and batch records connected, the Zettalab workspace links structured records with team file storage, so each test result stays attached to the batch it certifies.

The Two Methods in One Overview

The table shows the structural difference: PCR reads a molecular signature and is fast, while culture grows the organism and is definitive about viability but slow. The choice between them is therefore a choice about what the lab needs to know and when it needs to know it, not about which method is generically better.

PCR Testing: Speed and Molecular Sensitivity

PCR testing detects mycoplasma by amplifying DNA sequences conserved across the common contaminating species, with the result read from amplification or melting behavior. Its advantages are speed, turnaround within a working day in many formats, and the fact that it does not require the organisms to be viable or cultivable, which matters because some mycoplasma species grow poorly or not at all in standard culture conditions.

The same property that gives PCR its speed also defines its boundary: PCR detects DNA, and DNA can persist after organisms are dead. A positive PCR on a culture treated with antibiotics may reflect remnants rather than a live infection, which is why PCR positives in critical situations are confirmed by culture or by re-testing after treatment. The method's sensitivity also depends on the assay design, so the lab should know which species its chosen test covers.

Culture Testing: The Viability Reference

Culture testing inoculates the sample into broth and agar media designed for mycoplasma growth and observes colony formation, which can take days to several weeks depending on the species. Its value is the verdict it delivers: growth demonstrates viable, replicating organisms, which is the evidence that matters when the question is whether an infection is live. Culture has long served as the reference standard in testing strategies for exactly this reason.

Its limits are the mirror image of PCR's: culture is slow, and fastidious species that will not grow in the laboratory media can escape it. Culture therefore works best as the confirmation method behind routine molecular screening, rather than as the frontline test, a division of labor that combines PCR's speed with culture's viability proof.

Choosing and Combining the Methods

The working strategy for most labs is a combination: routine screening by PCR for speed, with culture confirmation for positives and for situations where a viability verdict matters, such as after antibiotic treatment or before releasing a culture bank. New cultures entering the lab are tested before use, and continuous cultures are tested on a fixed schedule, with the positive result triggering quarantine and the investigation the batch records support.

Whatever the method mix, the testing decision belongs in the records: which method, which date, which sample, and the result, attached to the culture batch. A testing program without records cannot prove a culture was clean at the time an experiment used it, which is precisely the assurance the records exist to provide. For teams that want testing records and experiment documentation connected, the Zettalab workspace links structured records with team file storage, so test results stay attached to the cultures and experiments they certify.

FAQ

Which mycoplasma test is more sensitive, PCR or culture?

The comparison depends on what sensitivity means. PCR is molecularly sensitive and detects nonviable DNA as well as live organisms, including species that will not grow in culture, so it rarely misses the DNA signature. Culture is the viability-sensitive method: a positive culture proves living organisms, but fastidious species can escape it. This is why the two methods are combined rather than treated as competitors, with PCR screening and culture confirmation.

How long does mycoplasma culture testing take?

Days to several weeks, depending on the species present and the laboratory's protocol. The slow turnaround is the method's main limitation and the reason culture is usually the confirmation step rather than the frontline screen. PCR fills the speed gap, returning results within a working day in many formats, which lets the lab act on a positive before the culture finishes growing.

Can PCR miss mycoplasma contamination?

Yes, in specific circumstances: the assay design may not cover the species present, very low organism loads may fall below detection, and inhibitors in the sample can suppress amplification. The lab should know which species its PCR test covers and include appropriate controls with each run. Culture confirmation catches some of what PCR misses, which is one more reason the methods are used together for critical calls.

How often should cell cultures be tested for mycoplasma?

On a fixed, recorded schedule rather than by suspicion, because contamination has no visible signs to trigger a test. A common pattern is testing continuous cultures on a monthly schedule and testing every new culture at entry, with any positive triggering quarantine and follow-up confirmation. The exact frequency is the lab's decision, but the essential properties are that testing is scheduled, documented, and linked to the culture batch.

What should I do when a mycoplasma test comes back positive?

Quarantine the affected culture, identify the batch through the tracking records, and check the other cultures that shared equipment or reagents with it. Confirm the positive, by culture or by re-testing, before making terminal decisions. Treated or discarded cultures are decided case by case, but the first actions are containment and impact assessment, and both depend on the testing and batch records existing.

Why would a lab run both PCR and culture on the same sample?

Because the methods answer different questions: PCR answers whether mycoplasma DNA is present, quickly, while culture answers whether viable organisms are growing. The combination matters after antibiotic treatment, when PCR can remain positive from dead remnants while culture clarifies whether the infection is actually gone, and it matters for positives that will trigger expensive decisions. The two methods are complementary evidence, not redundant duplication.

Conclusion

Mycoplasma testing is a scheduled discipline, and its method choice follows the question: PCR for fast molecular screening across the culture collection, culture for the viability verdict when a positive or a critical decision demands it. Combined with fixed schedules and records linked to culture batches, the methods turn a silent threat into a managed risk. To connect testing records with culture and experiment documentation, explore Zettalab's cloud-based R&D lab platform.